(PSEC) Prospect Capital - Ratings and Ratios
Term Loans, Mezzanine Debt, Private Equity, Bridge Financing, Senior Debt
PSEC EPS (Earnings per Share)
PSEC Revenue
Description: PSEC Prospect Capital
Prospect Capital Corporation is a business development company that specializes in providing financing solutions to middle-market companies, with a focus on mature businesses requiring mezzanine finance, later-stage growth capital, and leveraged buyouts. The company invests across various industries, with a particular emphasis on energy and industrial sectors, and has a geographical preference for the United States and Canada.
The companys investment strategy involves providing secured debt, senior debt, and equity investments to private and microcap public businesses, with a focus on primary origination and secondary loans/portfolios. Prospect Capital Corporation typically invests between $10 million to $500 million per transaction in companies with EBITDA between $5 million and $150 million, and has a diverse portfolio across various sectors, including aerospace and defense, chemicals, and renewable energy.
From a technical analysis perspective, the stocks recent price movement indicates a relatively stable trend, with the 20-day SMA at $3.36 and the 50-day SMA at $3.48. However, the 200-day SMA at $4.14 suggests a longer-term downtrend. The ATR of 0.09 indicates a moderate level of volatility, with a daily price movement of around 2.55%. Given the current price of $3.37, and considering the
Based on the companys investment strategy and portfolio composition, a key driver of Prospect Capital Corporations performance will be the overall health of its investee companies, particularly in the energy and industrial sectors. Any significant changes in the macroeconomic environment, such as interest rate movements or industry-specific disruptions, could impact the companys ability to generate returns on its investments. As such, investors should closely monitor the companys NAV, dividend payments, and portfolio composition to gauge its future prospects.
Additional Sources for PSEC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
PSEC Stock Overview
Market Cap in USD | 1,427m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception | 2004-07-27 |
PSEC Stock Ratings
Growth Rating | -16.1 |
Fundamental | - |
Dividend Rating | 57.6 |
Rel. Strength | -46.8 |
Analysts | 1 of 5 |
Fair Price Momentum | 3.52 USD |
Fair Price DCF | 40.83 USD |
PSEC Dividends
Dividend Yield 12m | 18.62% |
Yield on Cost 5y | 25.75% |
Annual Growth 5y | -0.85% |
Payout Consistency | 89.1% |
Payout Ratio | 21.2% |
PSEC Growth Ratios
Growth Correlation 3m | -71.9% |
Growth Correlation 12m | -90.1% |
Growth Correlation 5y | -18.9% |
CAGR 5y | 4.34% |
CAGR/Max DD 5y | 0.09 |
Sharpe Ratio 12m | -0.14 |
Alpha | -39.98 |
Beta | 0.457 |
Volatility | 19.91% |
Current Volume | 1626k |
Average Volume 20d | 2770.1k |
As of July 04, 2025, the stock is trading at USD 3.32 with a total of 1,626,024 shares traded.
Over the past week, the price has changed by +5.73%, over one month by +3.95%, over three months by -14.68% and over the past year by -30.93%.
Neither. Based on ValueRay´s Analyses, Prospect Capital is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -16.09 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PSEC is around 3.52 USD . This means that PSEC is currently overvalued and has a potential downside of 6.02%.
Prospect Capital has received a consensus analysts rating of 1.00. Therefor, it is recommend to sell PSEC.
- Strong Buy: 0
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 1
According to our own proprietary Forecast Model, PSEC Prospect Capital will be worth about 3.8 in July 2026. The stock is currently trading at 3.32. This means that the stock has a potential upside of +14.46%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 3 | -9.6% |
Analysts Target Price | 3 | -9.6% |
ValueRay Target Price | 3.8 | 14.5% |